[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[H.R. 10439 Introduced in House (IH)]
<DOC>
118th CONGRESS
2d Session
H. R. 10439
To amend the Public Health Service Act to expand research and education
with respect to endometrial cancer, and for other purposes.
_______________________________________________________________________
IN THE HOUSE OF REPRESENTATIVES
December 16, 2024
Mr. David Scott of Georgia (for himself and Ms. Norton) introduced the
following bill; which was referred to the Committee on Energy and
Commerce
_______________________________________________________________________
A BILL
To amend the Public Health Service Act to expand research and education
with respect to endometrial cancer, and for other purposes.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the ``Endometrial Cancer Research and
Education Act of 2024''.
SEC. 2. FINDINGS.
Congress finds the following:
(1) Endometrial cancer is cancer of the lining of the
uterus (or endometrium) and is the most common form of uterine
cancer.
(2) Endometrial cancer is the fourth most common cancer
diagnosed in women, after breast, lung, and colon cancer.
(3) Endometrial cancer mainly affects postmenopausal women,
with most women diagnosed between age 55 and 64.
(4) Women with polycystic ovary syndrome (PCOS) and uterine
leiomyoma have an increased risk of developing endometrial
cancer.
(5) Unlike most other types of cancer, the incidence of
endometrial cancer, particularly aggressive subtypes of such
cancer, has been increasing in the United States among all
women, particularly among African-American and Asian women,
with a 2.5 annual percent change for both groups.
(6) In comparison to non-Hispanic White women, African-
American women have significantly higher incidence rates of
aggressive endometrial cancers.
(7) Such incidence rates for Hispanic and Asian women are
equal to or lower than such incidence rates for non-Hispanic
White women.
(8) Although non-Hispanic White women are more likely to be
diagnosed with endometrial cancer in comparison to African-
American women, the rate of mortality is higher for African-
American women.
(9) Currently, the cause of such disparity is unknown.
Researchers are proposing investigative studies that link this
disparity to the relationship between delays in care,
aggressive late-stage diagnosis, and the time between diagnosis
and beginning treatment protocol for their cancer type. These
factors are often exacerbated by socioeconomic conditions that
affect access to innovative treatment, treatment completion,
patient-reported outcomes, and overall quality of life.
SEC. 3. EXPANDING RESEARCH AND EDUCATION WITH RESPECT TO ENDOMETRIAL
CANCER.
(a) National Institutes of Health.--Part B of title IV of the
Public Health Service Act (42 U.S.C. 284 et seq.) is amended by adding
at the end the following:
``SEC. 409K. ENDOMETRIAL CANCER.
``(a) In General.--The Director of NIH shall--
``(1) expand, intensify, and coordinate programs to conduct
and support research with respect to endometrial cancer;
``(2) communicate to medical professionals and researchers,
including through the endometrial cancer public education
program established under section 399V-8, the disparity in the
diagnosis of endometrial cancer between African-American women
and non-Hispanic White women and any new research relating to
endometrial cancer; and
``(3) ensure that all clinical trials conducted or
supported by the National Institutes of Health with respect to
endometrial cancer include at least 1 participant who is an
African-American woman.
``(b) Coordination With Other Institutes.--The Director of NIH
shall coordinate activities carried out by the Director pursuant to
subsection (a) with similar activities carried out by--
``(1) the Director of the Eunice Kennedy Shriver National
Institute of Child Health and Human Development;
``(2) the Director of the National Institute on Minority
Health and Health Disparities; and
``(3) the Director of the Office of Research on Women's
Health.
``(c) Authorization of Appropriations.--For purposes of carrying
out this section, there is authorized to be appropriated $500,000 for
each of fiscal years 2025 through 2027.''.
(b) Centers for Disease Control and Prevention.--Part P of title
III of the Public Health Service Act (42 U.S.C. 280g et seq.) is
amended by adding at the end the following:
``SEC. 399V-8. ENDOMETRIAL CANCER PUBLIC EDUCATION PROGRAM.
``(a) In General.--The Secretary, acting through the Director of
the Centers for Disease Control and Prevention, shall develop and
disseminate to the public informational materials on endometrial
cancer, including the incidence rate of such cancer, the risk factors
for developing such cancer, the increased risk for ethnic minority
women to develop such cancer, and the range of available treatments for
such cancer. Any informational material developed pursuant to the
previous sentence may be transmitted to a nonprofit organization;
institution of higher education; Federal, State, or local agency; or
media entity for purposes of disseminating such material to the public.
``(b) Inclusion.--The informational materials under subsection (a)
shall include materials targeted toward African-American women.
``(c) Consultation.--In developing and disseminating informational
materials under subsection (a), the Director of the Centers for Disease
Control and Prevention shall consult with the Administrator of the
Health Resources and Services Administration.
``(d) Authorization of Appropriations.--For purposes of carrying
out this section, there is authorized to be appropriated such sums as
may be necessary for each of fiscal years 2025 through 2027.''.
<all>